Pulmonary arteriovenous malformations and migraine: A new vision

Respiration

Volumn 76, Issue 2, 2008, Pages 228-233

  Post, M C ^a   Van Gent, M W F ^a   Snijder, R J ^a   Mager, J J ^a   Schonewille, W J ^a   Plokker, H W M ^a   Westermann, C J J ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Hereditary hemorrhagic telangiectasia; Migraine; Pulmonary arteriovenous malformations; Right to left shunt

Indexed keywords

ANATOMY; ARTIFICIAL EMBOLISM; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; PULMONARY SHUNT; RENDU OSLER WEBER DISEASE; REVIEW;

ARTERIOVENOUS MALFORMATIONS; HUMANS; LUNG; LUNG DISEASES; MIGRAINE DISORDERS;

EID: 49949099079     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134011     Document Type: Review

References (50)

1. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
2. Holmes DR Jr: Strokes and holes and headaches: are they a package deal? Lancet 2004;364:1840-1842.
3. The International Classification of Headache Disorders, ed 2. Cephalalgia 2004;24(suppl 1):9-160.
4. Silberstein SD: Migraine. Lancet 2004;363:381-391.
5. Stewart WF, Shechter A, Rasmussen BK: Migraine prevalence. A review of population-based studies. Neurology 1994;44:17-23.
6. Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537-542.
7. Lipton RB: Fair winds and foul headaches: risk factors and triggers of migraine. Neurology 2000;54:280-281.
8. Gardner KL: Genetics of migraine: an update. Headache 2006;46(suppl 1):S19-S24.
9. Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
10. Olesen J, Friberg L, Olsen TS, Iversen HK, Lassen NA, Andersen AR, Karle A: Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798.
11. Olesen J, Larsen B, Lauritzen M: Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-352.
12. Shovlin CL, Letarte M: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714-729.
13. Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ: Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 2006;43:371-377.
14. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J: Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-351.
15. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA: Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-195.
16. Westermann CJ, Rosina AF, De Vries V, de Coteau PA: The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 2003;116:324-328.
17. Begbie ME, Wallace GM, Shovlin CL: Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003;79:18-24.
18. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C: Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992;182:809-816.
19. Kjeldsen AD, Oxhoj H, Andersen PE, Elle B, Jacobsen JP, Vase P: Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999;116:432-439.
20. Mager JJ, Overtoom TT, Blauw H, Lammers JW, Westermann CJ: Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004;15:451-456.
21. Puskas JD, Allen MS, Moncure AC, Wain JC Jr, Hilgenberg AD, Wright C, Grillo HC, Mathisen DJ: Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg 1993;56:253-257.
22. White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, Shuman K, Kim W, Kinnison M, Mitchell SE: Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988;169:663-669.
23. Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, Ma TY, White RI: Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000;55:959-964.
24. Wilmshurst P, Nightingale S: Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001;100:215-220.
25. Hodgson CH, Burchell HB, Good CA, Clagett OT: Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous fistula: survey of a large family. N Engl J Med 1959;261:625-636.
26. Post MC, Letteboer TG, Mager JJ, Plokker TH, Kelder JC, Westermann CJ: A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005;128:2485-2489.
27. Thenganatt J, Schneiderman J, Hyland RH, Edmeads J, Mandzia JL, Faughnan ME: Migraines linked to intrapulmonary right-to-left shunt. Headache 2006;46:439-443.
28. Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W, Coon H, Mao R: Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 2006;140:463-470.
29. Steele JG, Nath PU, Burn J, Porteous ME: An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993;33:145-148.
30. Cottin V, Chinet T, Lavole A, Corre R, Marchand E, Reynaud-Gaubert M, Plauchu H, Cordier JF: Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 2007;86:1-17.
31. Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HW, Westermann CJ: Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66:202-205.
32. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M: Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005;64:1573-1577.
33. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, Diener HC, Buring JE: Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005;64:1020-1026.
34. Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
35. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ: Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
36. Fragoso YD: Reduction of migraine attacks during the use of warfarin. Headache 1997;37:667-668.
37. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN: Aspirin is efficacious for the treatment of acute migraine. Headache 2005;45:283-292.
38. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-67.
39. Wilmshurst P, Nightingale S: The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache 2006;46:429-434.
40. Post MC, Budts W: The relationship between migraine and right-to-left shunt: fact or fiction? Chest 2006;130:896-901.
41. Post MC, Luermans JG, Plokker HW, Budts W: Patent foramen ovale and migraine. Catheter Cardiovasc Interv 2007;69:9-14.
42. Roman G, Fisher M, Perl DP, Poser CM: Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol 1978;4:130-144.
43. Cottin V, Dupuis-Girod S, Lesca G, Cordier JF: Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler disease). Respiration 2007;74:361-378.
44. Marchesani F, Cecarini L, Pela R, Catalini G, Sabbatini A, Fianchini A, Sanguinetti CM: Pulmonary arteriovenous fistula in a patient with Rendu-Osler-Weber syndrome. Respiration 1997;64:367-370.
45. Aamodt AH, Borch-Iohnsen B, Hagen K, Stovner LJ, Asberg A, Zwart JA: Headache prevalence related to haemoglobin and ferritin. The HUNT Study. Cephalalgia 2004;24:758-762.
46. Whyte MK, Hughes JM, Jackson JE, Peters AM, Hempleman SC, Moore DP, Jones HA: Cardiopulmonary response to exercise in patients with intrapulmonary vascular shunts. J Appl Physiol 1993;75:321-328.
47. O'Connor TP, van der Koov D: Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 1988;8:2468-2476.
48. Van Gelderen EM, Du XY, Schoemaker RG, Saxena PR: Carotid blood flow distribution, haemodynamics and inotropic responses following calcitonin gene-related peptide in the pig. Eur J Pharmacol 1995;284:51-60.
49. Post MC, Thijs V, Herroelen L, Budts WI: Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-1440.
50. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL: Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-1320.